Skip to main content
Caplight Logo









Tianjin Zhonghe Gene Technology Co., Ltd.

Tianjin Zhonghe Gene Technology Co., Ltd.

Private
TianjinHealthcare & Life Scienceshttps://zhonghegene.com/

Last Round

Series A

Extension

Nov 18, 2025

Total Funding Raised

$5.6M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Tianjin Zhonghe Gene Technology Co., Ltd. is a biotechnology company that develops and manufactures gene synthesis equipment and provides bio-based gene synthesis services.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

enzymatic DNA synthesisDNA biosynthesizersynthetic biologygene synthesisDNA synthesis reagentsbiotech equipmentDNA assemblyprotein designsynbioDNA printingbiotech lab equipmentprecision medicineDNA data storagemodified nucleotides

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tianjin Zhonghe Gene Technology Co., Ltd. Comparables

Compare Tianjin Zhonghe Gene Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Tianjin Zhonghe Gene Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DNA Script
81%
Evonetix
77%
Telesis Bio
76%

Tianjin Zhonghe Gene Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionNov 18, 2025
VC RoundFeb 22, 2024
AngelJan 29, 2023

Tianjin Zhonghe Gene Technology Co., Ltd. Investors

Notable investors and investment history

Tianjin Zhonghe Gene Technology Co., Ltd. investors
InvestorRounds
联想创投集团 (Lenovo Capital and Incubator Group)VC Round
CAS Venture CapitalSeries A Extension
Beiyang Haitang Venture Capital FundVC Round
Apricot CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 18, 2025

    $3M round led by CAS Venture Capital.

  • Feb 22, 2024

    $2.8M round led by Beiyang Haitang Venture Capital Fund.

Tianjin Zhonghe Gene Technology Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Tianjin Zhonghe Gene Technology Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Tianjin Zhonghe Gene Technology Co., Ltd.'s valuation, stock price, and market status.

Is Tianjin Zhonghe Gene Technology Co., Ltd. a public or private company?

Tianjin Zhonghe Gene Technology Co., Ltd. is a private company.

What is the current stock price of Tianjin Zhonghe Gene Technology Co., Ltd.?

Tianjin Zhonghe Gene Technology Co., Ltd. is a private company with no public stock price. Caplight tracks Tianjin Zhonghe Gene Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Tianjin Zhonghe Gene Technology Co., Ltd. worth (valuation)?

Valuation information for Tianjin Zhonghe Gene Technology Co., Ltd. is not publicly available.

Can I buy Tianjin Zhonghe Gene Technology Co., Ltd. stock?

Tianjin Zhonghe Gene Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Tianjin Zhonghe Gene Technology Co., Ltd.'s last funding round?

Tianjin Zhonghe Gene Technology Co., Ltd.'s most recent funding round was Series A Extension on November 18, 2025.

Who are the main investors in Tianjin Zhonghe Gene Technology Co., Ltd.?

Key investors in Tianjin Zhonghe Gene Technology Co., Ltd. include Beiyang Haitang Venture Capital Fund.

Will Tianjin Zhonghe Gene Technology Co., Ltd. IPO soon?

No public IPO plans have been announced for Tianjin Zhonghe Gene Technology Co., Ltd..

How can I track Tianjin Zhonghe Gene Technology Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tianjin Zhonghe Gene Technology Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTianjin
Year Founded2022
Last FundingNov 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?